Bio-Rad Laboratories Inc (BIO)

416.09 -4.01 (-0.95%)
Close USD Disclaimer
416.09 0.00 (0.00%)
Day's Range
415.70 - 423.59
52 wk Range
344.63 - 768.48
Prev. Close
420.10
Open
418.41
Volume
134,664
Average Vol.(3m)
247,219
1-Year Change
-44.8%
Market Cap
12.35B
Beta
0.929
P/E Ratio
-1.98
Type
Equity
Market
United States
ISIN
US0905722072
CUSIP
090572207
Shares Outstanding
29,824,130
Revenue
2.82B
EPS
-202.20
Dividend (Yield)
N/A (N/A%)
Next Earnings Date
Feb 09, 2023
Strong Sell Strong Buy Sell Neutral Buy
Buy
How do you feel today about Bio-Rad Laboratories Inc?
or

Bio-Rad Labs News & Analysis

  • © Reuters.  sizes=

    Bio-Rad Labs Misses Q3 EPS by 18c

    Bio-Rad Labs (BIO) reported Q3 EPS of $2.60, $0.18 worse than the analyst estimate of $2.78. Revenue for the quarter came in at $680.8 million versus the consensus estimate of $679.94...

    • Investing.com
  • © Reuters sizes=

    3 Rumors Buzzing Around Wall Street Today

    By Investing.com Staff Stocks fell again Monday with the Nasdaq closing at a two-year low. Despite the sell-off, several rumors drove trading action in some select stocks today. Below we...

    • Investing.com
  • © Reuters sizes=

    Bio-Rad Labs and Qiagen in Combination Talks - WSJ

    By Sam Boughedda Shares of diagnostics firm Bio-Rad Laboratories Inc (NYSE:BIO) spiked higher before falling on Monday after a report from The Wall Street Journal said the company is in...

    • Investing.com
  • © Reuters.  sizes=

    Bio-Rad Labs Tops Q2 EPS by 58c

    Bio-Rad Labs (BIO) reported Q2 EPS of $3.38, $0.58 better than the analyst estimate of $2.80. Revenue for the quarter came in at $691.1 million versus the consensus estimate of $682.62...

    • Investing.com
  • © Reuters.  sizes=

    Bio-Rad Labs Tops Q1 EPS by $1.54

    Bio-Rad Labs (BIO) reported Q1 EPS of $4.94, $1.54 better than the analyst estimate of $3.40. Revenue for the quarter came in at $700 million versus the consensus estimate of $675.1...

    • Investing.com
  • © Reuters.  sizes=

    Bio-Rad Laboratories Up 7% After Investor Day

    By Sam Boughedda Investing.com -- Bio-Rad Laboratories Inc (NYSE:BIO), the life science and clinical diagnostic products firm gave an optimistic forecast at its investor day on Friday,...

    • Investing.com

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles